Market Research Report Store Mast Therapeutics Inc (MSTX) – Pharmaceuticals & H

Market Research Report Store has been recently published a fresh report"Mast Therapeutics Inc (MSTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/shop/mast-therapeutics-inc-mstx-pharmaceuticals- healthcare-deals-and-alliances-profile-4 Request a sample, click here [email protected] Description Mast Therapeutics Inc (Mast Therapeutics) is a biopharmaceutical company, which develops clinical-stage therapies for serious or life-threatening diseases. The company develops therapies for sickle cell disease, a chronic, genetic disorder for rare or orphan disease. The company’s lead product MST-188 (also known as vepoloxamer) is being developed for the treatment of of vaso-occlusive crisis in patients with sickle cell disease. Its pipeline includes development programs in the areas of adjunctive thrombolytic therapy, heart failure, resuscitation and major trauma. The company develops MST-188 utilizing its proprietary technology molecular adhesion and sealant technology (MAST). The company is headquartered in San Diego, California, the US. Mast Therapeutics Inc (MSTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. Scope